TNFRSF11A and sarcopenia: Furthermore, the RANK/RANKL system s instrumental in muscle metabolism, and inhibition of RANKL significantly improved muscle insulin sensitivity and reduced anti-myogenic and inflammatory gene expression in muscle, which potentially represents a novel therapeutic approach for sarcopenia [32].